CLINICAL_TRIALS
trial_result
· 2013-10-25
Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder [Phase 3]
Summary
Phase 3 trial evaluating safety and efficacy of Levomilnacipran ER for major depressive disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-10-25